Systolic bp and mortality in older adults with CKD

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 9, 2015, Pages 1553-1559

  Weiss, Jessica W ^a   Peters, Dawn ^a   Yang, Xiuhai ^b   Petrik, Amanda ^b   Smith, David H ^b   Johnson, Eric S ^b   Thorp, Micah L ^b   Morris, Cynthia ^a   O’Hare, Ann M ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE; TOBACCO USE; VERY ELDERLY; AGE; BLOOD PRESSURE; BRITISH COLUMBIA; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; OREGON; PATHOPHYSIOLOGY; SYSTOLE; WASHINGTON;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BRITISH COLUMBIA; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; OREGON; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SYSTOLE; WASHINGTON;

EID: 84941200168     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11391114     Document Type: Article

References (26)

1. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, Le Fevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311: 507-520, 2014
2. JATOS Study Group: Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 31: 2115-2127, 2008
3. Kidney Disease Improving Global Outcomes (KDIGO) Blood Pressure Work Group: KDIGOC linical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int 2(Suppl 2, Issue 5): 337-414, 2012
4. Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Valleé M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program: The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 30: 485-501, 2014
5. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members: 2013 ESH/ESCGuidelines for themanagement of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31: 1281-1357, 2013
6. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA; The Hypertension Detection and Follow-up Program Cooperative Group: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. Hypertension 13(Suppl): I80-I93, 1989
7. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD; The MRFIT Research Group: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. JAMA 268: 3085-3091, 1992
8. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G; Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877-884, 1994
9. Upadhyay A, Earley A, Haynes SM, Uhlig K: Systematic review: Blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med 154: 541-548, 2011
10. O’Hare AM, Kaufman JS, Covinsky KE, Landefeld CS, McFarland LV, Larson EB: Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: Is the evidence base relevant to older adults? Ann Intern Med 150: 717-724, 2009
11. O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS: Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18: 2758-2765, 2007
12. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265: 3255-3264, 1991
13. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O’Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A; The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350: 757-764, 1997
14. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ; HYVET Study Group: Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358: 1887-1898, 2008
15. Weiss JW, Johnson ES, Petrik A, Smith DH, Yang X, Thorp ML: Systolic blood pressure and mortality among older communitydwelling adultswith CKD. Am J Kidney Dis 56: 1062-1071, 2010
16. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K: Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med 159: 233-242, 2013
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
18. Mancia G, Schumacher H, Redon J, Verdecchia P, Schmieder R, Jennings G, Yusoff K, Ryden L, Liu GL, Teo K, Sleight P, Yusuf S: Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation 124: 1727-1736, 2011
19. Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, Pepine CJ: Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 304: 61-68, 2010
20. Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, Donnan GA, Bath PM; PROFESS Investigators: Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 306: 2137-2144, 2011
21. Bowling CB, Sharma P, Fox CS, O’Hare AM, Muntner P: Prevalence of reduced estimated glomerular filtration rate among the oldest old from1988-1994 through2005-2010. JAMA310: 1284-1286, 2013
22. Fried TR, Tinetti ME, Towle V, O’Leary JR, Iannone L: Effects of benefits and harms on older persons’ willingness to take medication for primary cardiovascular prevention. Arch Intern Med 171: 923-928, 2011
23. Balkrishnan R: Predictors of medication adherence in the elderly. Clin Ther 20: 764-771, 1998
24. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW: Adverse drug events in ambulatory care. N Engl J Med 348: 1556-1564, 2003
25. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW: Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 294: 716-724, 2005
26. Peralta CA, Shlipak MG, Wassel-Fyr C, Bosworth H, Hoffman B, Martins S, Oddone E, Goldstein MK: Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension 50: 474-480, 2007